English | Español

Bristol-Myers Squibb
+ Community
Ruth de Jauregui | Jun 4, 2017

Advaxis, Bristol-Myers Squibb to collaborate in metastatic cervical cancer study
+ Regulatory
Robert Hadley | May 31, 2017

FDA greenlights review of Bristol-Myers Squibb’s Opdivo for liver cancer
+ Regulatory
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
+ Technology/Innovation
Robert Hadley | May 14, 2017

Partnership to launch study of two drugs, chemotherapy to treat lung cancer
+ Technology/Innovation
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer
Robert Hadley | Apr 14, 2017

FDA to speed Opdivo review for use as colorectal cancer drug
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes